Scientists from Massachusetts Institute of Technology (MA, USA) have developed a urine test that can identify proteins associated with lung cancer. It is hoped the nanoparticle-based test could reduce the quantity of false positives and improve early detection.
Scientists from New York University Abu Dhabi (UAE) have developed a new microfluidic platform compatible with atomic force microscopy that could be used to perform liquid cancer biopsies. The tool could also be used to identify new metastatic mechano-biomarkers.
A joint study conducted by researchers from the University of the Ryukyus (Nishihara, Japan) and NEC Corporation (Tokyo, Japan) has identified a novel diagnostic biomarker for acute adult T-cell leukemia/lymphoma.
Scientists at the Johns Hopkins Kimmel Cancer Center (MD, USA) have completed a proof-of-principle study with results indicating the potential for a urine test for prostate cancer. The study identified cancer-specific changes in urinary RNAs and metabolites.
Liquid biopsy to predict clinical response to immunotherapy in metastatic non-small cell lung cancer?
Results from research carried out at Perelman School of Medicine (University of Pennsylvania, PA, USA) and the Abramson Cancer Center (PA, USA) suggest that a blood test could be used to predict the clinical response to immunotherapy in non-small cell lung cancer.
Researchers from Brigham and Women’s Hospital (MA, USA) report a new quantitative technique, based on measuring the fraction of T cells in a tumor sample, that could be used to predict the risk of melanoma recurrence.
Scientists from Duke University (NC, USA), UCLA (CA, USA) and the University of Birmingham (UK) have reported a novel noninvasive technique that could detect a viral strain associated with oropharyngeal cancer in saliva samples.
Researchers have designed a non-invasive and inexpensive chip-based optical biosensor with increased sensitivity to detect the presence and progression of cancerous tumors. The cancer protein biomarker S100A4 was detected at concentrations of 300 picomolar in a synthetic urine sample.
Researchers based at the University of Toronto (ON, CA) have developed a microfluidic device that could be used to separate malignant plasma cells from healthy red blood cells. The device could have the potential to detect and monitor blood cancer.
A new study from the University of Texas at Austin (TX, USA) reports a desorption electrospray ionization mass spectrometry-based technique that could improve clinical thyroid cancer diagnosis.